Wet wrap therapy in children with moderate to severe atopic dermatitis in a multidisciplinary treatment program

Journal of Allergy and Clinical Immunology: In Practice

Volumn 2, Issue 4, 2014, Pages 400-406

  Nicol, Noreen Heer ^a,b   Boguniewicz, Mark ^c   Strand, Matthew ^c   Klinnert, Mary D ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

^c DEPARTMENT OF MEDICINE   (United States)

Author keywords

Atopic dermatitis; Management; Outcomes; Wet wrap therapy

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT CARE; SCORING SYSTEM; SYSTEMIC THERAPY; THERAPY; TREATMENT FAILURE; TREATMENT INDICATION; WET WRAP THERAPY; ADOLESCENT; ALGORITHM; BANDAGE; DERMATITIS, ATOPIC; DISEASE COURSE; EVALUATION STUDY; HYDROTHERAPY; INFANT; INTERDISCIPLINARY COMMUNICATION; MULTIMODALITY CANCER THERAPY; PRACTICE GUIDELINE; PRESCHOOL CHILD; TREATMENT OUTCOME; UTILIZATION;

ADOLESCENT; ALGORITHMS; BANDAGES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMBINED MODALITY THERAPY; DERMATITIS, ATOPIC; DISEASE PROGRESSION; FEMALE; HUMANS; HYDROTHERAPY; INFANT; INTERDISCIPLINARY COMMUNICATION; MALE; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 84904016806     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2014.04.009     Document Type: Article

References (29)

1. Odhiambo J.A., Williams H.C., Clayton T.O., Robertson C.F., Asher M.I. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. JAllergy Clin Immunol 2009, 124:1251-1258.e23. Group IPTS.
2. Kapoor R., Menon C., Hoffstad O., Bilker W., Leclerc P., Margolis D.J. The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. JAm Acad Dermatol 2008, 58:68-73.
3. Boguniewicz M., Leung D.Y. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011, 242:233-246.
4. Cork M.J., Robinson D.A., Vasilopoulos Y., Ferguson A., Moustafa M., MacGowan A., et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. JAllergy Clin Immunol 2006, 118:3-21.
5. Chamlin S.L. The psychosocial burden of childhood atopic dermatitis. Dermatol Ther 2006, 19:104-107.
6. Akdis C.A., Akdis M., Bieber T., Bindslev-Jensen C., Boguniewicz M., Eigenmann P., et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. JAllergy Clin Immunol 2006, 118:152-169.
7. Schneider L., Tilles S., Lio P., Boguniewicz M., Beck L., LeBovidge J., et al. Atopic dermatitis: a practice parameter update 2012. JAllergy Clin Immunol 2013, 131:295-299.
8. Nicol N.H. Atopic dermatitis: the (wet) wrap-up. Am J Nurs 1987, 87:1560-1563.
9. Boguniewicz M., Nicol N., Kelsay K., Leung D.Y. Amultidisciplinary approach to evaluation and treatment of atopic dermatitis. Semin Cutan Med Surg 2008, 27:115-127.
10. Boguniewicz M., Nicol N. Conventional therapy for atopic dermatitis. Immunol Allergy Clin N Am 2002, 22:107-124.
11. Nicol N.H., Boguniewicz M. Successful strategies in atopic dermatitis management. Dermatol Nurs 2008, (Suppl):3-18.
12. Charman C., Williams H. Outcome measures of disease severity in atopic eczema. Arch Dermatol 2000, 136:788-790.
13. Weisshaar E., Diepgen T.L., Bruckner T., Fartasch M., Kupfer J., Lob-Corzilius T., et al. Itch intensity evaluated in the German Atopic Dermatitis Intervention Study (GADIS): correlations with quality of life, coping behaviour and SCORAD severity in 823 children. Acta Derm Venereol 2008, 88:234-239.
14. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993, 186:23-31.
15. Sladden M.J., Mortimer N.J., Milligan A.M. Wet wraps in atopic eczema: the dangers of inadequately sized 'negative' clinical trials. Clin Exp Dermatol 2005, 30:454-455.
16. Carel K., Bratton D.L., Miyazawa N., Gyorkos E., Kelsay K., Bender B., et al. TheAtopic Dermatitis Quickscore (ADQ): validation of a new parent-administered atopic dermatitis scoring tool. Ann Allergy Asthma Immunol 2008, 101:500-507.
17. Dabade T.S., Davis D.M., Wetter D.A., Hand J.L., McEvoy M.T., Pittelkow M.R., et al. Wet dressing therapy in conjunction with topical corticosteroids is effective for rapid control of severe pediatric atopic dermatitis: experience with 218 patients over 30 years at Mayo Clinic. JAm Acad Dermatol 2012, 67:100-106.
18. Abeck D., Brockow K., Mempel M., Fesq H., Ring J. Treatment of acute exacerbated atopic eczema with emollient-antiseptic preparations using the "wet wrap" ("wet pajama") technique. Hautarzt 1999, 50:418-421.
19. Beattie P.E., Lewis-Jones M.S. Apilot study on the use of wet wraps in infants with moderate atopic eczema. Clin Exp Dermatol 2004, 29:348-353.
20. Devillers A.C., de Waard-van der Spek F.B., Mulder P.G., Oranje A.P. Treatment of refractory atopic dermatitis using 'wet-wrap' dressings and diluted corticosteroids: results of standardized treatment in both children and adults. Dermatology 2002, 204:50-55.
21. Foelster-Holst R., Nagel F., Zoellner P., Spaeth D. Efficacy of crisis intervention treatment with topical corticosteroid prednicarbat with and without partial wet-wrap dressing in atopic dermatitis. Dermatology 2006, 212:66-69.
22. Wolkerstorfer A., Visser R.L., De Waard van der Spek F.B., Mulder P.G., Oranje A.P. Efficacy and safety of wet-wrap dressings in children with severe atopic dermatitis: influence of corticosteroid dilution. Br J Dermatol 2000, 143:999-1004.
23. Hon K.L., Wong K.Y., Cheung L.K., Ha G., Lam M.C., Leung T.F., et al. Efficacy and problems associated with using a wet-wrap garment for children with severe atopic dermatitis. JDermatolog Treat 2007, 18:301-305.
24. Oranje A.P.W.A., De Waard-van der Spek F.B. Treatment of erythrodermic atopic dermatitis with "wet-wrap" fluticasone propionate 0.05% cream/emollient 1: 1 dressings. JDermatolog Treat 1999, 10:73-74.
25. Hindley D., Galloway G., Murray J., Gardener L. Arandomised study of "wet wraps" versus conventional treatment for atopic eczema. Arch Dis Child 2006, 91:164-168.
26. Lee J.H., Lee S.J., Kim D., Bang D. The effect of wet-wrap dressing on epidermal barrier in patients with atopic dermatitis. JEur Acad Dermatol Venereol 2007, 21:1360-1368.
27. Devillers A.C., Oranje A.P. Efficacy and safety of 'wet-wrap' dressings as an intervention treatment in children with severe and/or refractory atopic dermatitis: a critical review of the literature. Br J Dermatol 2006, 154:579-585.
28. Schmitt J., Langan S., Williams H.C. What are the best outcome measurements for atopic eczema? A systematic review. JAllergy Clin Immunol 2007, 120:1389-1398. European Dermato-Epidemiology Network.
29. Devillers A.C., Oranje A.P. Wet-wrap treatment in children with atopic dermatitis: a practical guideline. Pediatr Dermatol 2012, 29:24-27.